Ishibe N - Search Results

1

p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells.

Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, Harris CC. Ambs S, et al. Among authors: ishibe n. Nat Med. 1998 Dec;4(12):1371-6. doi: 10.1038/3957. Nat Med. 1998. PMID: 9846573

2

Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung.

Breathnach OS, Ishibe N, Williams J, Linnoila RI, Caporaso N, Johnson BE. Breathnach OS, et al. Among authors: ishibe n. Cancer. 1999 Oct 1;86(7):1165-73. doi: 10.1002/(sici)1097-0142(19991001)86:7<1165::aid-cncr10>3.0.co;2-9. Cancer. 1999. PMID: 10506700

3

Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.

Chatterjee N, Hartge P, Cerhan JR, Cozen W, Davis S, Ishibe N, Colt J, Goldin L, Severson RK. Chatterjee N, et al. Among authors: ishibe n. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1415-21. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15342441

4

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, Struewing JP. Biesecker BB, et al. Among authors: ishibe n. Am J Med Genet. 2000 Aug 14;93(4):257-63. doi: 10.1002/1096-8628(20000814)93:4<257::aid-ajmg1>3.0.co;2-8. Am J Med Genet. 2000. PMID: 10946349

5

ATM mutations and protein expression are not associated with familial B-CLL cases.

Ishibe N, Goldin LR, Caporaso NE, Sgambati MT, Dean M, Albitar M, Manshouri T, Gerrard B, Marti GE. Ishibe N, et al. Leuk Res. 2003 Oct;27(10):973-5. doi: 10.1016/s0145-2126(03)00067-5. Leuk Res. 2003. PMID: 12860021 No abstract available.

6

Chordoma: incidence and survival patterns in the United States, 1973-1995.

McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. McMaster ML, et al. Among authors: ishibe n. Cancer Causes Control. 2001 Jan;12(1):1-11. doi: 10.1023/a:1008947301735. Cancer Causes Control. 2001. PMID: 11227920

7

A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men.

Ishibe N, Stampfer M, Hunter DJ, Hennekens C, Kelsey KT. Ishibe N, et al. Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):855-6. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10952105 No abstract available.

8

Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry.

Ishibe N, Sgambati MT, Fontaine L, Goldin LR, Jain N, Weissman N, Marti GE, Caporaso NE. Ishibe N, et al. Leuk Lymphoma. 2001 Jun;42(1-2):99-108. doi: 10.3109/10428190109097681. Leuk Lymphoma. 2001. PMID: 11699227

9

Understanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis.

Ishibe N, Freedman AN. Ishibe N, et al. Cancer Invest. 2001;19(5):524-39. doi: 10.1081/cnv-100103850. Cancer Invest. 2001. PMID: 11458819 Review. No abstract available.

10

Use of epidermal growth factor receptor mutation analysis in patients with advanced non-small-cell lung cancer to determine erlotinib use as first-line therapy.

Ishibe N, Carlson J, Ramsey SD, Freedman A, Schully S. Ishibe N, et al. PLoS Curr. 2011 Jun 21;3:RRN1245. doi: 10.1371/currents.RRN1245. PLoS Curr. 2011. PMID: 21743846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters